Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Week In Review: Xynomic Signs $502 Million Deal For Boehringer's RAF Inhibitor

Article By:
ChinaBio® Today
Saturday, November 4, 2017 4:58 PM EST
Xynomic Pharma, a US-Shanghai clinical-stage oncology drug developer, acquired exclusive global rights to a 2nd-generation RAF inhibitor from Boehringer Ingelheim. Xynomic, hoping BI 882370 is a best-in-class drug, agreed to a $502 million package.
E Trump's Kvittle

Article By:
Vivian Lewis
Tuesday, May 23, 2017 12:24 AM EST
The President should not be blamed for all the fall in our currency, because even before he hit the scene the US$ was up way over trend, and near its 1985 peak. To revive industry, as Trump proposes, he needs a cheaper currency.
In this article: , ALV, CZZ, F, GSK, MXE, TTM, VALE, VOD, CH, ANCUF, AQUNF, BKSHF, CGRIF, CMDXF, DLKGF, NPSNY, OROCF, PPEHF, TCTZF, BLRX, SHPG, TEVA, CGEN, CUBA, INPCF, BNTC, BNTCW
Week In Review: Week's Deals Create New China Life Science Alliances

Article By:
ChinaBio® Today
Saturday, August 27, 2016 5:14 PM EST
Almost a half billion dollars in deals were worked out in the China biotech space last week, the largest being Luye Medical Group's commitment of $300 million to bring up-to-date healthcare to a large healthcare complex.
Another Bad Day For Stocks
I like $BLRX. What was the Gamida cell news that I missed?